DISCO Pharmaceuticals is advancing a differentiated pipeline of highly selective, surfaceome-targeted therapies for hard-to-treat tumors. By uncovering novel cell surface target pairs through its disruptive platform, the company designs bispecific ADCs and T-cell engagers with the potential for unprecedented specificity and a broad therapeutic window to drive potent anti-tumor activity.
Leadership & Board
Current Number of Employees37
Current LinkedIn Followers3,062
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$36M
Total Amount Raised$36M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$36M
Latest Funding Amount$36M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
DISCO Pharmaceuticals had 37 employees as of September 14, 2026. The number of employees increased by 0 (0.00%) week-over-week.
37Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
DISCO Pharmaceuticals had 3,062 followers as of September 14, 2026. The number of followers increased by 29 (0.96%) week-over-week.
3,062Latest Followers Count
29(0.96%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.